MAFLD: A holistic view to redefining fatty liver disease

Mohammed Eslam¹, Jacob George²

Affiliations

¹ Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, NSW, Australia. Electronic address: mohammed.eslam@sydney.edu.au.
² Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, NSW, Australia. Electronic address: jacob.george@sydney.edu.au.

PMID: 33453330
DOI: 10.1016/j.jhep.2020.12.027

Comment

MAFLD: A holistic view to redefining fatty liver disease

Mohammed Eslam et al. J Hepatol. 2021 Apr.

. 2021 Apr;74(4):983-985.

doi: 10.1016/j.jhep.2020.12.027. Epub 2021 Jan 13.

Authors

Mohammed Eslam¹, Jacob George²

Affiliations

¹ Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, NSW, Australia. Electronic address: mohammed.eslam@sydney.edu.au.
² Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, NSW, Australia. Electronic address: jacob.george@sydney.edu.au.

PMID: 33453330
DOI: 10.1016/j.jhep.2020.12.027

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.

Comment on

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.
Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour JF, Schattenberg JM, Kawaguchi T, Arrese M, Valenti L, Shiha G, Tiribelli C, Yki-Järvinen H, Fan JG, Grønbæk H, Yilmaz Y, Cortez-Pinto H, Oliveira CP, Bedossa P, Adams LA, Zheng MH, Fouad Y, Chan WK, Mendez-Sanchez N, Ahn SH, Castera L, Bugianesi E, Ratziu V, George J. Eslam M, et al. J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8. J Hepatol. 2020. PMID: 32278004 Review.
A new definition for non-alcoholic fatty liver disease.
Poniachik J, Roblero JP, Urzúa A, Cattaneo M. Poniachik J, et al. J Hepatol. 2021 Apr;74(4):982-983. doi: 10.1016/j.jhep.2020.09.002. Epub 2020 Dec 16. J Hepatol. 2021. PMID: 33340572 No abstract available.
"Dual aetiology fatty liver disease": A recently proposed term associated with potential pitfalls.
Moreno C, Sheron N, Tiniakos D, Lackner C, Mathurin P; EASL Consortium for the Study of Alcohol-related LiVer disease in Europe (SALVE). Moreno C, et al. J Hepatol. 2021 Apr;74(4):979-982. doi: 10.1016/j.jhep.2020.11.004. Epub 2020 Dec 16. J Hepatol. 2021. PMID: 33340582 No abstract available.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

MAFLD: A holistic view to redefining fatty liver disease

Affiliations

MAFLD: A holistic view to redefining fatty liver disease

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical